Skip to main content

Table 2 Estimates of prevalence of obesity among Iranian adults 25–64 years old

From: Third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia

  Obesity Overweighta
  National
estimateb
Prevalence
(95% CI)
National
estimateb
Prevalence
(95% CI)
Age     
   25–34 (n = 1081) 1.8 14.4 (11.5–17.8) 4.1 31.8 (29.0–34.7)
   35–44 (n = 1113) 2.4 26.7 (22.7–31.1) 3.5 39.4 (36.1–42.8)
   45–54 (n = 1069) 1.8 29.3 (25.6–33.2) 2.5 39.8 (36.4–43.3)
   55–64 (n = 970) 0.9 27.4 (24.1–31.0) 1.3 39.3 (35.1–43.6)
Sex     
   Males (n = 2121) 2.3 14.2 (12.2–16.5) 6.0 37.5 (35.0–40.1)
   Females (n = 2112) 4.7 30.6 (27.3–34.0) 5.4 35.1 (32.8–37.6)
Residential area     
   Urban (n = 2853) 5.3 23.8 (21.5–26.2) 8.6 38.2 (36.2–40.2)
   Rural (n = 1380) 1.7 18.5 (14.5–23.4) 2.8 31.7 (28.4–35.3)
Total national estimate
(n = 4233)
7.0 22.3 (20.2–24.5) 11.4 36.3 (34.6–38.1)
  1. CI: confidence interval
  2. a In non-obese subjects
  3. b Rounded to the nearest million
  4. Estimates are weighted for age, sex, and residential area on the basis of the population of Iran in 2006